<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7221157</article-id><article-id pub-id-type="doi">10.3389/fimmu.2020.00944</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Coronavirus Disease (COVID-19&#x02013;SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cena</surname><given-names>Hellas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/334360/overview"/></contrib><contrib contrib-type="author"><name><surname>Chieppa</surname><given-names>Marcello</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/67707/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Public Health, Experimental and Forensic Medicine-Dietetics and Clinical Nutrition Laboratory, University of Pavia</institution>, <addr-line>Pavia</addr-line>, <country>Italy</country></aff><aff id="aff2"><sup>2</sup><institution>Clinical Nutrition and Dietetics Service, Unit of Internal Medicine and Endocrinology, ICS Maugeri IRCCS</institution>, <addr-line>Pavia</addr-line>, <country>Italy</country></aff><aff id="aff3"><sup>3</sup><institution>National Institute of Gastroenterology &#x0201c;S. de Bellis&#x0201d;, Institute of Research</institution>, <addr-line>Castellana Grotte</addr-line>, <country>Italy</country></aff><aff id="aff4"><sup>4</sup><institution>Depatrment of Immunology and Cell Biology, European Biomedical Research Institute of Salerno EBRIS</institution>, <addr-line>Salerno</addr-line>, <country>Italy</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Vida Abedi, Geisinger Health System, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Anastasia N. Vlasova, The Ohio State University, United States; Alberto Finamore, Council for Agricultural and Economics Research (CREA), Italy</p></fn><corresp id="c001">*Correspondence: Hellas Cena <email>hellas.cena@unipv.it</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Nutritional Immunology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>07</day><month>5</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>11</volume><elocation-id>944</elocation-id><history><date date-type="received"><day>26</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Cena and Chieppa.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Cena and Chieppa</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Novel coronavirus disease (COVID-19) was declared a global pandemic on March 11, 2020. The outbreak first occurred in Wuhan, Hubei, China, in December 2019 and hit Italy heavily in February 2020. Several countries are adopting complete or partial lockdown to contain the growth of COVID-19 infection. These measures may affect people's mental health and well-being but are necessary to avoid spreading the pandemic. There has been a gradual increase in studies exploring prevention and control measures, and we recommend paying close attention to nutrition, which may contribute to modulating some important consequences of COVID-19 infection, as such pro-inflammatory cytokine storm.</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd>nutrition</kwd><kwd>polyphenols</kwd><kwd>diabetes</kwd><kwd>incidence</kwd><kwd>cytokine storm</kwd></kwd-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="63"/><page-count count="6"/><word-count count="4343"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Novel coronavirus disease (COVID-19) spread to all regions of Italy on January 31, 2020. The northern region of Lombardy was identified as the center of the two main Italian clusters of cases. On March 11, 2020, the Director-General of the WHO declared COVID-19 a global pandemic as the virus spread rapidly from China to the rest of the world, particularly Europe (<xref rid="B1" ref-type="bibr">1</xref>). Currently, the scientific community is sharing potentially useful data to treat patients and protect the population, but the details of COVID-19 infection are still largely unknown, and thus options for risk assessment and pharmacological intervention have only been partially developed.</p><p>By March 26, more than 511,603 confirmed cases of COVID-19 had been reported, of which 80,589 were registered in Italy, so far the country with the highest mortality rate (8.215) (<xref rid="B2" ref-type="bibr">2</xref>). Four Regions in Italy have reported 59,173 cases of COVID-19, including 34,889 confirmed infections solely in Italy's epicentral Lombardy region, corresponding to more than a third of the total number of infected people in the entire country (Ministry of Health). Italy's mortality rate may be partially explained by the country's relatively higher proportion of older people.</p><p>Similarly to what has been observed in China, the most common symptoms were fever, cough, and fatigue (<xref rid="B3" ref-type="bibr">3</xref>). Acute respiratory distress syndrome (ARDS) was the main cause of death (<xref rid="B4" ref-type="bibr">4</xref>). Older adults and people with chronic illness are most vulnerable to the worst effects of the disease.</p><p>Knowledge about novel COVID-19 is based on a few months of observation and some similarities to Severe Acute Respiratory Syndrome (SARS) and to Middle East Respiratory Syndrome coronavirus (MERS-CoV). Despite the lower case fatality rate than MERS and SARS, COVID-19 has so far proven extremely contagious. Moreover, a significant percentage of those who are infected require hospitalization in an intensive care unit.</p><p>Here we speculate on a possible link between nutritional status and COVID-19 mortality, based on data emerging from the Italian National Health System. Furthermore, while waiting for clinical trials to shed light on the clinical efficacy and beneficial effects of antibodies and anti-inflammatory cytokines, we highlight nutritionally derived products that may inhibit the inflammatory cytokine secretion caused by COVID-19 infection.</p></sec><sec id="s2"><title>Diabetes And COVID-19 Infection</title><p>Subjects with diabetes are at risk of infections and have severe disease when infected with a respiratory virus, showing an increased risk of mortality (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Data from MERS-CoV, which broke out in 2012 in Saudi Arabia, showed that the severity and length of the pulmonary pathology observed were increased in those affected by type 2 diabetes, which likely deregulates immune response (<xref rid="B6" ref-type="bibr">6</xref>). Data on COVID-19 in patients with diabetes is limited at present (<xref rid="B5" ref-type="bibr">5</xref>). The Chinese Centre for Disease Control and Prevention published a report of 72,314 cases of COVID-19, showing an increased mortality rate in subjects with diabetes (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Diabetes is the most common comorbidity observed in COVID-19-positive deceased patients in Italy after hypertension (<xref rid="B8" ref-type="bibr">8</xref>). Available data on pre-existing comorbidities updated on April 9, 2020, and extracted from clinical charts showed hypertension and diabetes before hospitalization in 69.9% (<italic>n</italic> = 1,015) and 33.8% (<italic>n</italic> = 462) of COVID-19-positive deceased patients, respectively (<xref rid="B9" ref-type="bibr">9</xref>). The same data showed that among 18,366 COVID-19-positive deceased patients, 61.0% (<italic>n</italic> = 886) presented three or more comorbidities that had been diagnosed before COVID-19 infection, 20.7% (<italic>n</italic> = 301) had two, 18.8% (<italic>n</italic> = 215) had one, and only 3.5% (<italic>n</italic> = 51) had no pre-existing pathology (<xref rid="B9" ref-type="bibr">9</xref>).</p><p>Diabetes is prevalent in our population, and most patients with diabetes type II are overweight or affected by obesity (<xref rid="B10" ref-type="bibr">10</xref>). However, obesity is not included within the WHO &#x0201c;five-by-five&#x0201d; framework of non-communicable diseases (NCDs) and risk factors, and data on BMI are not collected in a standardized manner<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>. Unfortunately, we do not yet have weight, height, and waist circumference data for all patients with laboratory-confirmed COVID-19, and, therefore, we cannot disentangle the effects of adiposity on lung function and immune response to viral infection. Excess body weight and increased visceral adiposity are habitually associated with metabolic alterations such as insulin dysregulation, high fasting glucose levels, hyperlipidemia, or systemic hypertension, which cause dysregulation of the immune system through mediation in various immune, metabolic, and thrombogenic responses. However, the clinical impact of this immune dysregulation on susceptibility to and severity and outcome of viral infections and on lung function is not yet clearly understood (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p><p>Nevertheless, preliminary data from GiViTi (<ext-link ext-link-type="uri" xlink:href="https://giviti.marionegri.it/covid-19/">https://giviti.marionegri.it/covid-19/</ext-link>) presented on March 31, 2020, showed a high prevalence of obesity (26%) and overweight (41%) in 928 Italian patients, median age 65 years, from 76 different Italian ICUs, confirming evidence available so far in the literature. Recent data on patients with laboratory-confirmed COVID-19 treated at an academic health institution in New York City, the epicenter of the COVID-19 outbreak in the United States, between March 1, 2020, and April 2, 2020, with follow up through April 7, 2020 (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>) showed that obesity, after age, was linked to more severe coronavirus cases, with a substantially higher odds ratio than any cardiovascular or pulmonary disease.</p><p>Obese and obese-diabetic subjects undergo modifications of the innate and adaptive immune response at different phases, characterized by a state of chronic, and low-grade inflammation and a high basal concentration of several pro-inflammatory cytokines such as alpha-TNF, MCP-1, and IL-6, leading to a defect in innate immunity (<xref rid="B14" ref-type="bibr">14</xref>). Recent evidence indicates that obesity not only increases the risk of infection and of complications for the individual but also increases the chance of appearance of a more virulent viral strain, prolonging virus shedding, and eventually increasing the overall mortality rate of an influenza pandemic (<xref rid="B15" ref-type="bibr">15</xref>).</p><p>Hence, both diabetes and obesity impair the immune response to viral infections like influenza and influenza vaccination through alterations of the cellular immune system (<xref rid="B16" ref-type="bibr">16</xref>). Studies so far suggest that diabetics, as well as subjects with obesity, are at a greater risk of hospitalization and increased complications from influenza (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Compared with vaccinated healthy-weight adults, vaccinated obese adults have twice the risk of influenza or influenza-like illness despite equal serological response to vaccination (<xref rid="B19" ref-type="bibr">19</xref>). This should be considered one of the challenges to be overcome in vaccine development and/or medications to combat this virulent respiratory virus and prevent future epidemics similar to COVID-19.</p></sec><sec id="s3"><title>Hyperinflammation in COVID-19 Infected Patients</title><p>Obesity is also associated with chronic low-grade inflammation, dysbiosis, and increased secretion of inflammatory cytokines, including interleukin 6 (IL-6) (<xref rid="B20" ref-type="bibr">20</xref>). Elevated plasma levels of pro-inflammatory cytokines are observed in COVID-19 infected patients; in particular, IL-6 and ferritin release have been identified as predictors of fatality (<xref rid="B21" ref-type="bibr">21</xref>). Several studies focusing on previous outbreaks of severe influenza confirmed that the mortality caused by organ injury could be reduced by immunomodulatory agents (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Currently, a study on the safety and efficacy of Tocilizumab is being conducted (ClinicalTrials.gov Identifier: NCT04317092) (<xref rid="B24" ref-type="bibr">24</xref>) to assess its capacity to suppress the virally driven hyperinflammation and acute respiratory syndrome caused by COVID-19.</p><p>As mentioned previously, COVID-19-related deaths are due to acute respiratory distress syndrome (ARDS); nonetheless, data indicate that the COVID-19 virus is detectable in stool of infected patients, suggesting systemic manifestations (<xref rid="B25" ref-type="bibr">25</xref>). In line with this observation, reports indicate abundant expression of ACE2 in absorptive enterocytes of the GI tract (<xref rid="B25" ref-type="bibr">25</xref>) and diarrhea as among the most frequent infection symptoms (<xref rid="B26" ref-type="bibr">26</xref>). Inflammation of intestinal mucosa may result in increased intestinal permeability with a consequent cascade of events that cause persistent inflammation, worsening the infection-related symptoms. Immune homeostasis is a dynamic process maintained by a complex interplay between the gut microbiota and host mucosal immune system (<xref rid="B27" ref-type="bibr">27</xref>). Dysbiosis, defined as imbalances in gut microbial species, is now a well-recognized factor in the pathogenesis of age-associated frailty (<xref rid="B28" ref-type="bibr">28</xref>). It is possible that COVID-19 mortality is increased in older patients with comorbidities associated with intestinal dysbiosis, as this could support systemic chronic inflammation in the host. Nonetheless, only future studies will clarify this aspect.</p></sec><sec id="s4"><title>Can Nutritionally Derived Products Help To Contain/Alleviate COVID-19-Induced Inflammation?</title><p>ACE2-expressing epithelial cells are the primary targets of COVID-19. Similarly to other pulmonary viral infections, following primary exposure, the progeny proliferate in the host cells, which consequently die and release their contents. COVID-19 is now able to infect other cells, including alveolar macrophages (<xref rid="B29" ref-type="bibr">29</xref>). Activated or infected immune cells secrete excessive pro-inflammatory cytokines and chemokines, fuelling a vicious circle leading to pulmonary tissue damage. Data accumulating from COVID-19 patients indicate that these patients might have a cytokine storm syndrome, with markedly higher levels of IFN-&#x003b3;, CCL-2, CCL-3, TNF, and the aforementioned IL-6 (<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>).</p><p>For optimal functioning of the immune system, an adequate nutritional status is required. This is well-acknowledged from evidence linking nutritional deficiencies to the functionality of the immune system (<xref rid="B33" ref-type="bibr">33</xref>). Poor nutrition leads to poor immune defense, and it is frequently associated with impaired immunity and increased susceptibility to infection. Nevertheless, nutrient inadequacies and deficiencies in our habitual diet are common (<xref rid="B34" ref-type="bibr">34</xref>), and immune function may be improved by restoring nutrients to recommended levels, increasing resistance to infection, and hastening recovery once infected (<xref rid="B35" ref-type="bibr">35</xref>)<sub>.</sub></p><p>Furthermore, studies have revealed inadequate micronutrient levels in patients who were hospitalized in the infectious disease department, including thiamine, selenium, zinc, and vitamin B6 deficiencies (<xref rid="B36" ref-type="bibr">36</xref>), which were associated with adverse clinical outcomes. Early detection, prevention, and treatment should aim at decreasing the inflammatory response and avoiding the excessive post-inflammatory immune suppression, defined as compensatory response (<xref rid="B37" ref-type="bibr">37</xref>), that is observed in many such patients (<xref rid="B38" ref-type="bibr">38</xref>).</p><p>Various micronutrients are essential for immunocompetence, particularly vitamins A, C, D, E, B2, B6, and B12, folic acid, iron, selenium, and zinc, as well as macronutrients likely omega 3 fatty acids (<xref rid="B39" ref-type="bibr">39</xref>) and bioactive components as polyphenols (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>During recent years, our groups, together with several others worldwide, demonstrated the ability of nutritionally derived bioactive compounds to suppress inflammatory cytokine release (<xref rid="B40" ref-type="bibr">40</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>). In particular, the administration of several plant-derived polyphenols to <italic>in vitro</italic> cultured immune cells suppressed the release of inflammatory cytokines (<xref rid="B44" ref-type="bibr">44</xref>). Traditional Chinese herbal medicines for influenza treatment demonstrated potential antiviral activity (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Polyphenol bioavailability has been long discussed, as many have observed health benefits, but few have observed circulating traces of bioactive compounds (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). Nonetheless, exposure of the epithelial barrier to a polyphenol-rich environment can efficiently activate local immune suppression and tissue repair mechanisms (<xref rid="B49" ref-type="bibr">49</xref>), and systemic benefits may be related to the release of circulating microRNA, defined as small non-coding RNA molecules, with anti-inflammatory effects (<xref rid="B50" ref-type="bibr">50</xref>). Indeed, even if orally introduced, bioactive dietary factors induce miRNA synthesis, these are packaged into exosomes and released into the bloodstream to act systemically (<xref rid="B51" ref-type="bibr">51</xref>). Dietary factors are emerging as anti-inflammatory miRNA promoters able to regulate metabolic functions, inflammation, and oxidation systemically (<xref rid="B52" ref-type="bibr">52</xref>&#x02013;<xref rid="B55" ref-type="bibr">55</xref>). Furthermore, herb extracts may combine antiviral, anti-inflammatory, and antioxidant activity, and tissue-repair properties (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>The effects of polyphenols may antagonize the acute respiratory distress induced by macrophage-produced pro-inflammatory cytokine storm. On the left (RED background), COVID-19 infection results in cytokines, and chemokine release by alveolar macrophages. Chemokines further recruit circulating immune cells. On the right (GREEN background), polyphenol exposure can block the immune cell inflammatory program and, at the same time, promote the SLPI release crucial for tissue repair.</p></caption><graphic xlink:href="fimmu-11-00944-g0001"/></fig><p>Altogether, these observations suggest that people may benefit from a correct nutritional intake, particularly during this period of uncertainty. Choosing dietary regimes that may potentially work as adjuvants for preventing undesired hyper-inflammation might be particularly useful for patients with mild signs of infection (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Deleterious effects of the anti-COVID-19 strategy (RED) can impact the base of the Mediterranean diet pyramid. An increase in polyphenol uptake and substitution of meat with legume-derived proteins can help prevent chronic inflammation, and reduction of caloric intake may compensate for the reduction in physical activity. Alcohol consumption is discouraged for healthy people and is detrimental for patients, even in the absence of clinical symptoms.</p></caption><graphic xlink:href="fimmu-11-00944-g0002"/></fig></sec><sec sec-type="discussion" id="s5"><title>Discussion</title><p>General recommendations for healthy adults over 50 years of age observing a period of lockdown and thus with limited options for physical activity should focus on healthy dietary patterns. These can be generally described as those rich in plant-based foods, including fresh fruits and vegetables, soya, nuts, good sources of antioxidants (<xref rid="B58" ref-type="bibr">58</xref>), and omega-3 fatty acids (<xref rid="B59" ref-type="bibr">59</xref>) and low in saturated fats and trans fats, animal-derived proteins, and added/refined sugars (<xref rid="B60" ref-type="bibr">60</xref>). Moreover, mild energy restriction is recommended for obese and obese-diabetic patients (<xref rid="B15" ref-type="bibr">15</xref>). Most of these dietary targets can be met in our country by means of the well-known and traditionally familiar Mediterranean diet (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>), which is rich in polyphenols with immune-protective and anti-inflammatory activities, playing an adjuvant role in both prophylaxis and therapy (<xref rid="B61" ref-type="bibr">61</xref>). The scientific community is already discussing how to manage future epidemic outbreaks by learning from the current experience (<xref rid="B63" ref-type="bibr">63</xref>). Future studies should also focus on the effects of nutrition on immune function, identifying target population subgroups with the most vulnerable immune systems, such as the elderly and those with comorbidities.</p></sec><sec id="s6"><title>Author Contributions</title><p>HC and MC wrote the manuscript.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn id="fn0001"><p><sup>1</sup>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.worldobesity.org/training-and-events/events/wof-webinar-the-collision-of-two-pandemics-covid-19-and-obesity">https://www.worldobesity.org/training-and-events/events/wof-webinar-the-collision-of-two-pandemics-covid-19-and-obesity</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>WHO</collab></person-group>
<article-title>WHO Virtual Press Conference on COVID-19</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2">https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2</ext-link> (accessed March 16, 2020)</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group>
<article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title>. <source>Intensive Care Med</source>. (<year>2020</year>). <pub-id pub-id-type="doi">10.1007/s00134-020-06028-z</pub-id>. [Epub ahead of print].</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University</collab></person-group> Available online at: <ext-link ext-link-type="uri" xlink:href="https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6">https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6</ext-link></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name></person-group>. <article-title>Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China</article-title>. <source>Clin Infect Dis</source>. (<year>2020</year>) pii: ciaa272. <pub-id pub-id-type="doi">10.1093/cid/ciaa272</pub-id>. [Epub ahead of print].<?supplied-pmid 32176772?><pub-id pub-id-type="pmid">32176772</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Misra</surname><given-names>A</given-names></name></person-group>
<article-title>Clinical considerations for patients with diabetes in times of COVID-19 epidemic</article-title>. <source>Diabetes Metab Syndr</source>. (<year>2020</year>) <volume>14</volume>:<fpage>211</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.dsx.2020.03.002</pub-id><pub-id pub-id-type="pmid">32172175</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulcsar</surname><given-names>KA</given-names></name><name><surname>Coleman</surname><given-names>CM</given-names></name><name><surname>Beck</surname><given-names>SE</given-names></name><name><surname>Frieman</surname><given-names>MB</given-names></name></person-group>. <article-title>Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection</article-title>. <source>JCI Insight</source>. (<year>2019</year>) <volume>4</volume>:<fpage>131774</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.131774</pub-id><?supplied-pmid 31550243?><pub-id pub-id-type="pmid">31550243</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>McGoogan</surname><given-names>JM</given-names></name></person-group>
<article-title>Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention</article-title>. <source>J Am Med Assoc</source>. (<year>2020</year>). <pub-id pub-id-type="doi">10.1001/jama.2020.2648</pub-id>. [Epub ahead of print].</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>ISS</collab></person-group>
<source>Characteristics of COVID-19 Patients Dying in Italy Report Based on Available Data on April 9th, 2020</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_9_april_2020.pdf">https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_9_april_2020.pdf</ext-link></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="webpage">ISTAT, 2015 Statistical Yearbook,. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.istat.it/it/files//2017/07/REPORT_DIABETE.pdf">https://www.istat.it/it/files//2017/07/REPORT_DIABETE.pdf</ext-link></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peralta</surname><given-names>GP</given-names></name><name><surname>Marcon</surname><given-names>A</given-names></name><name><surname>Carsin</surname><given-names>A</given-names></name><name><surname>Abramson</surname><given-names>MJ</given-names></name><name><surname>Accordini</surname><given-names>S</given-names></name><name><surname>Amaral</surname><given-names>AF</given-names></name><etal/></person-group>. <article-title>Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study</article-title>. <source>Thorax</source>. (<year>2020</year>) <volume>75</volume>:<fpage>313</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1136/thoraxjnl-2019-213880</pub-id><?supplied-pmid 32098862?><pub-id pub-id-type="pmid">32098862</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcon</surname><given-names>A</given-names></name><name><surname>Corsico</surname><given-names>A</given-names></name><name><surname>Cazzoletti</surname><given-names>L</given-names></name><name><surname>Bugiani</surname><given-names>M</given-names></name><name><surname>Accordini</surname><given-names>S</given-names></name><name><surname>Almar</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Body mass index, weight gain, and other determinants of lung function decline in adult asthma</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2009</year>) <volume>123</volume>:<fpage>1069</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2009.01.040</pub-id><?supplied-pmid 19321196?><pub-id pub-id-type="pmid">19321196</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>AS</given-names></name><name><surname>Obin</surname><given-names>MS</given-names></name></person-group>. <article-title>Obesity and the role of adipose tissue in inflammation and metabolism</article-title>. <source>Am J Clin Nutr</source>. (<year>2006</year>) <volume>83</volume>:<fpage>461S</fpage>&#x02212;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/83.2.461S</pub-id><?supplied-pmid 16470013?><pub-id pub-id-type="pmid">16470013</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baffi</surname><given-names>CW</given-names></name><name><surname>Wood</surname><given-names>L</given-names></name><name><surname>Winnica</surname><given-names>D</given-names></name><name><surname>Strollo</surname><given-names>PJ</given-names><suffix>Jr</suffix></name><name><surname>Gladwin</surname><given-names>MT</given-names></name><name><surname>Que</surname><given-names>LG</given-names></name><etal/></person-group>. <article-title>Metabolic syndrome and the lung</article-title>. <source>Chest</source>. (<year>2016</year>) <volume>149</volume>:<fpage>1525</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.chest.2015.12.034</pub-id><?supplied-pmid 26836925?><pub-id pub-id-type="pmid">26836925</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>C</given-names></name><name><surname>Manuel</surname><given-names>A</given-names></name></person-group>
<article-title>Obesity, respiratory disease and pulmonary infections</article-title>. <source>Ann Res Hosp</source>. (<year>2017</year>) <volume>1</volume>:<fpage>38</fpage>
<pub-id pub-id-type="doi">10.21037/arh.2017.08.06</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrilli</surname><given-names>CM</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Rajagopalan</surname><given-names>H</given-names></name><name><surname>O'Donnell</surname><given-names>LF</given-names></name><name><surname>Chernyak</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City</article-title>. (<year>2020</year>) <pub-id pub-id-type="doi">10.1101/2020.04.08.20057794</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luzi</surname><given-names>L</given-names></name><name><surname>Radaelli</surname><given-names>MG</given-names></name></person-group>. <article-title>Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic</article-title>. <source>Acta Diabetol</source>. (<year>2020</year>). <pub-id pub-id-type="doi">10.1007/s00592-020-01522-8</pub-id>. [Epub ahead of print].<?supplied-pmid 32249357?><pub-id pub-id-type="pmid">32249357</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>PA</given-names></name><name><surname>Paich</surname><given-names>HA</given-names></name><name><surname>Handy</surname><given-names>J</given-names></name><name><surname>Karlsson</surname><given-names>EA</given-names></name><name><surname>Schultz-Cherry</surname><given-names>S</given-names></name><name><surname>Hudgens</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The antibody response to influenza vaccination is not impaired in type 2 diabetics</article-title>. <source>Vaccine</source>. (<year>2015</year>) <volume>33</volume>:<fpage>3306</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.05.043</pub-id><pub-id pub-id-type="pmid">26044491</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allard</surname><given-names>R</given-names></name><name><surname>Leclerc</surname><given-names>P</given-names></name><name><surname>Tremblay</surname><given-names>C</given-names></name><name><surname>Tannenbaum</surname><given-names>TN</given-names></name></person-group>. <article-title>Diabetes and the severity of pandemic influenza A (H1N1) infection</article-title>. <source>Diabetes Care</source>. (<year>2010</year>) <volume>33</volume>:<fpage>1491</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.2337/dc09-2215</pub-id><?supplied-pmid 20587722?><pub-id pub-id-type="pmid">20587722</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>JS</given-names></name><name><surname>Galindo-Fraga</surname><given-names>A</given-names></name><name><surname>Ortiz-Hern&#x000e1;ndez</surname><given-names>AA</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Hunsberger</surname><given-names>S</given-names></name><name><surname>Gal&#x000e1;n-Herrera</surname><given-names>JF</given-names></name><etal/></person-group>. <article-title>Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses</article-title>. <source>Influenza Other Respir Viruses</source>. (<year>2019</year>) <volume>13</volume>:<fpage>3</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/irv.12618</pub-id><?supplied-pmid 30515985?><pub-id pub-id-type="pmid">30515985</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>WD</given-names></name><name><surname>Beck</surname><given-names>MA</given-names></name></person-group>. <article-title>Obesity impairs the adaptive immune response to influenza virus</article-title>. <source>Ann Am Thorac Soc</source>. (<year>2017</year>) <volume>14</volume>(<issue>Suppl. 5</issue>):S406&#x02013;9. <pub-id pub-id-type="doi">10.1513/AnnalsATS.201706-447AW</pub-id><?supplied-pmid 29161078?><pub-id pub-id-type="pmid">29161078</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rexrode</surname><given-names>KM</given-names></name><name><surname>Pradhan</surname><given-names>A</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group>. <article-title>Relationship of total and abdominal adiposity with CRP and IL-6 in women</article-title>. <source>Ann Epidemiol</source>. (<year>2003</year>) <volume>13</volume>:<fpage>674</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/S1047-2797(03)00053-X</pub-id><?supplied-pmid 14599731?><pub-id pub-id-type="pmid">14599731</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudo</surname><given-names>K</given-names></name><name><surname>Takasaki</surname><given-names>J</given-names></name><name><surname>Manabe</surname><given-names>T</given-names></name><name><surname>Uryu</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>R</given-names></name><name><surname>Kuroda</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan</article-title>. <source>PLoS ONE.</source> (<year>2012</year>) <volume>7</volume>:<fpage>e32280</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0032280</pub-id><?supplied-pmid 22393395?><pub-id pub-id-type="pmid">22393395</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>BJ</given-names></name><name><surname>Chan</surname><given-names>KW</given-names></name><name><surname>Lin</surname><given-names>YP</given-names></name><name><surname>Zhao</surname><given-names>GY</given-names></name><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2008</year>) <volume>105</volume>:<fpage>8091</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0711942105</pub-id><?supplied-pmid 18523003?><pub-id pub-id-type="pmid">18523003</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Chinese Clinical Trial Registry</collab></person-group>
<source>A Multicenter, Randomized Controlled Trial for the Efficacy and Safety of Tocilizumab in the Treatment of New Coronavirus Pneumonia (COVID-19)</source>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.chictr.org.cn/showprojen.aspx?proj=49409">http://www.chictr.org.cn/showprojen.aspx?proj=49409</ext-link> (accessed March 6, 2020).</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>Z</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process</article-title>. <source>Gut Immun</source>. (<year>2020</year>). <pub-id pub-id-type="doi">10.1136/gutjnl-2020-320953</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>S</given-names></name></person-group>. <article-title>Another decade, another coronavirus</article-title>. <source>N Engl J Med.</source> (<year>2020</year>) <volume>382</volume>:<fpage>760</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMe2001126</pub-id><?supplied-pmid 31978944?><pub-id pub-id-type="pmid">31978944</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eri</surname><given-names>R</given-names></name><name><surname>Chieppa</surname><given-names>M</given-names></name></person-group>. <article-title>Messages from the inside</article-title>. the dynamic environment that favors intestinal homeostasis. <source>Front Immunol</source>. (<year>2013</year>) <volume>4</volume>:<fpage>323</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00323</pub-id><?supplied-pmid 24130559?><pub-id pub-id-type="pmid">24130559</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livshits</surname><given-names>G</given-names></name><name><surname>Kalinkovich</surname><given-names>A</given-names></name></person-group>. <article-title>Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis</article-title>. <source>Ageing Res Rev</source>. (<year>2019</year>) <volume>56</volume>:<fpage>100980</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2019.100980</pub-id><?supplied-pmid 31726228?><pub-id pub-id-type="pmid">31726228</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>YH</given-names></name><name><surname>Yang</surname><given-names>ZQ</given-names></name></person-group>. <article-title>The cytokine storm of severe influenza and development of immunomodulatory therapy</article-title>. <source>Cell Mol Immunol</source>. (<year>2016</year>) <volume>13</volume>:<fpage>3</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2015.74</pub-id><?supplied-pmid 26189369?><pub-id pub-id-type="pmid">26189369</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Gruta</surname><given-names>NL</given-names></name><name><surname>Kedzierska</surname><given-names>K</given-names></name><name><surname>Stambas</surname><given-names>J</given-names></name><name><surname>Doherty</surname><given-names>PC</given-names></name></person-group>. <article-title>A question of self-preservation: immunopathology in influenza virus infection</article-title>. <source>Immunol Cell Biol</source>. (<year>2007</year>) <volume>85</volume>:<fpage>85</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/sj.icb.7100026</pub-id><?supplied-pmid 17213831?><pub-id pub-id-type="pmid">17213831</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>PK</given-names></name><name><surname>McAuley</surname><given-names>DF</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Tattersall</surname><given-names>RS</given-names></name><name><surname>Manson</surname><given-names>JJ</given-names></name><etal/></person-group>. <article-title>COVID-19: consider cytokine storm syndromes and immunosuppression</article-title>. <source>Lancet</source>. <volume>395</volume>:<fpage>1033</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30628-0</pub-id><?supplied-pmid 32192578?><pub-id pub-id-type="pmid">32192578</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source>Lancet</source>. (<year>2020</year>) <volume>395</volume>:<fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id><?supplied-pmid 31986264?><pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rijkers</surname><given-names>GT</given-names></name></person-group>. <article-title>Nutrition, immunity and human health</article-title>. <source>Br J Nutrit.</source> (<year>2013</year>) <volume>114</volume>:<fpage>1329</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114513002158</pub-id><?supplied-pmid 23829950?><pub-id pub-id-type="pmid">23829950</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruins</surname><given-names>MJ</given-names></name><name><surname>Van Dael</surname><given-names>P</given-names></name><name><surname>Eggersdorfer</surname><given-names>M</given-names></name></person-group>. <article-title>The role of nutrients in reducing the risk for noncommunicable diseases during aging</article-title>. <source>Nutrients.</source> (<year>2019</year>) <volume>11</volume>:<fpage>85</fpage>. <pub-id pub-id-type="doi">10.3390/nu11010085</pub-id><?supplied-pmid 30621135?><pub-id pub-id-type="pmid">30621135</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggini</surname><given-names>S</given-names></name><name><surname>Pierre</surname><given-names>A</given-names></name><name><surname>Calder</surname><given-names>PC</given-names></name></person-group>. <article-title>Immune function and micronutrient requirements change over the life course</article-title>. <source>Nutrients.</source> (<year>2018</year>) <volume>10</volume>:<fpage>1531</fpage>. <pub-id pub-id-type="doi">10.3390/nu10101531</pub-id><?supplied-pmid 30336639?><pub-id pub-id-type="pmid">30336639</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dizdar</surname><given-names>OS</given-names></name><name><surname>Baspinar</surname><given-names>O</given-names></name><name><surname>Kocer</surname><given-names>D</given-names></name><name><surname>Dursun</surname><given-names>ZB</given-names></name><name><surname>Avci</surname><given-names>D</given-names></name><name><surname>Karak&#x000fc;kc&#x000fc;</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Nutritional risk, micronutrient status and clinical outcomes: a prospective observational study in an infectious disease clinic</article-title>. <source>Nutrients</source>. (<year>2016</year>) <volume>8</volume>:<fpage>124</fpage>. <pub-id pub-id-type="doi">10.3390/nu8030124</pub-id><?supplied-pmid 26938553?><pub-id pub-id-type="pmid">26938553</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>LF</given-names></name><name><surname>Cuenca</surname><given-names>AG</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name><name><surname>Ang</surname><given-names>D</given-names></name><name><surname>Bihorac</surname><given-names>A</given-names></name><name><surname>McKinley</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care</article-title>. <source>J Trauma Acute Care Surg</source>. (<year>2012</year>) <volume>72</volume>:<fpage>1491</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1097/TA.0b013e318256e000</pub-id><?supplied-pmid 22695412?><pub-id pub-id-type="pmid">22695412</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guti&#x000e9;rrez</surname><given-names>S</given-names></name><name><surname>Svahn</surname><given-names>SL</given-names></name><name><surname>Johansson</surname><given-names>ME</given-names></name></person-group>. <article-title>Effects of Omega-3 Fatty Acids on Immune Cells</article-title>. <source>Int J Mol Sci.</source> (<year>2019</year>) <volume>20</volume>:<fpage>5028</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20205028</pub-id><?supplied-pmid 31614433?><pub-id pub-id-type="pmid">31614433</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dicarlo</surname><given-names>M</given-names></name><name><surname>Teti</surname><given-names>G</given-names></name><name><surname>Verna</surname><given-names>G</given-names></name><name><surname>Liso</surname><given-names>M</given-names></name><name><surname>Cavalcanti</surname><given-names>E</given-names></name><name><surname>Sila</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Quercetin exposure suppresses the inflammatory pathway in intestinal organoids from winnie mice</article-title>. <source>Int J Mol Sci</source>. (<year>2019</year>) <volume>20</volume>:<fpage>5771</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20225771</pub-id><?supplied-pmid 31744123?><pub-id pub-id-type="pmid">31744123</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cianciosi</surname><given-names>D</given-names></name><name><surname>Forbes-Hern&#x000e1;ndez</surname><given-names>TY</given-names></name><name><surname>Afrin</surname><given-names>S</given-names></name><name><surname>Gasparrini</surname><given-names>M</given-names></name><name><surname>Reboredo-Rodriguez</surname><given-names>P</given-names></name><name><surname>Manna</surname><given-names>PP</given-names></name><etal/></person-group>. <article-title>Phenolic compounds in honey and their associated health benefits: a review</article-title>. <source>Molecules</source>. (<year>2018</year>) <volume>23</volume>:<fpage>2322</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23092322</pub-id><?supplied-pmid 30208664?><pub-id pub-id-type="pmid">30208664</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Santis</surname><given-names>S</given-names></name><name><surname>Galleggiante</surname><given-names>V</given-names></name><name><surname>Scandiffio</surname><given-names>L</given-names></name><name><surname>Liso</surname><given-names>M</given-names></name><name><surname>Sommella</surname><given-names>E</given-names></name><name><surname>Sobolewski</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Secretory leukoprotease inhibitor (Slpi) expression is required for educating murine dendritic cells inflammatory response following quercetin exposure</article-title>. <source>Nutrients</source>. (<year>2017</year>) <volume>9</volume>:<fpage>706</fpage>. <pub-id pub-id-type="doi">10.3390/nu9070706</pub-id><?supplied-pmid 28684695?><pub-id pub-id-type="pmid">28684695</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvecchio</surname><given-names>FR</given-names></name><name><surname>Vadrucci</surname><given-names>E</given-names></name><name><surname>Cavalcanti</surname><given-names>E</given-names></name><name><surname>De Santis</surname><given-names>S</given-names></name><name><surname>Kunde</surname><given-names>D</given-names></name><name><surname>Vacca</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Polyphenol administration impairs T-cell proliferation by imprinting a distinct dendritic cell maturational profile</article-title>. <source>Eur J Immunol</source>. (<year>2015</year>) <volume>45</volume>:<fpage>2638</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201545679</pub-id><?supplied-pmid 26096294?><pub-id pub-id-type="pmid">26096294</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalcanti</surname><given-names>E</given-names></name><name><surname>Vadrucci</surname><given-names>E</given-names></name><name><surname>Delvecchio</surname><given-names>FR</given-names></name><name><surname>Addabbo</surname><given-names>F</given-names></name><name><surname>Bettini</surname><given-names>S</given-names></name><name><surname>Liou</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation</article-title>. <source>PLoS ONE</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e88898</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0088898</pub-id><?supplied-pmid 24558444?><pub-id pub-id-type="pmid">24558444</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Lim</surname><given-names>CE</given-names></name><name><surname>Kang</surname><given-names>HJ</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group>. <article-title>Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials</article-title>. <source>PLoS ONE</source>. (<year>2011</year>) <volume>6</volume>:<fpage>e28093</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028093</pub-id><?supplied-pmid 22164232?><pub-id pub-id-type="pmid">22164232</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>PM</given-names></name><name><surname>Wong</surname><given-names>CK</given-names></name><name><surname>Fung</surname><given-names>KP</given-names></name><name><surname>Fong</surname><given-names>CY</given-names></name><name><surname>Wong</surname><given-names>EL</given-names></name><name><surname>Lau</surname><given-names>JT</given-names></name><etal/></person-group>. <article-title>Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study</article-title>. <source>Am J Chin Med</source>. (<year>2006</year>) <volume>34</volume>:<fpage>13</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X0600359X</pub-id><?supplied-pmid 16437735?><pub-id pub-id-type="pmid">16437735</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name></person-group>. <article-title>Polyphenols and bioavailability: an update</article-title>. <source>Crit Rev Food Sci Nutr</source>. (<year>2019</year>) <volume>59</volume>:<fpage>2040</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2018.1437023</pub-id><?supplied-pmid 29405736?><pub-id pub-id-type="pmid">29405736</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leri</surname><given-names>M</given-names></name><name><surname>Scuto</surname><given-names>M</given-names></name><name><surname>Ontario</surname><given-names>ML</given-names></name><name><surname>Calabrese</surname><given-names>V</given-names></name><name><surname>Calabrese</surname><given-names>EJ</given-names></name><name><surname>Bucciantini</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Healthy effects of plant polyphenols: molecular mechanisms</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>:<fpage>1250</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21041250</pub-id><?supplied-pmid 32070025?><pub-id pub-id-type="pmid">32070025</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Santis</surname><given-names>S</given-names></name><name><surname>Cavalcanti</surname><given-names>E</given-names></name><name><surname>Mastronardi</surname><given-names>M</given-names></name><name><surname>Jirillo</surname><given-names>E</given-names></name><name><surname>Chieppa</surname><given-names>M</given-names></name></person-group>. <article-title>Nutritional keys for intestinal barrier modulation</article-title>. <source>Front Immunol</source>. (<year>2015</year>) <volume>6</volume>:<fpage>612</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00612</pub-id><?supplied-pmid 26697008?><pub-id pub-id-type="pmid">26697008</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corr&#x000ea;a</surname><given-names>TA</given-names></name><name><surname>Rogero</surname><given-names>MM</given-names></name></person-group>. <article-title>Polyphenols regulating microRNAs and inflammation biomarkers in obesity</article-title>. <source>Nutrition</source>. (<year>2019</year>) <volume>59</volume>:<fpage>150</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.nut.2018.08.010</pub-id><?supplied-pmid 30471527?><pub-id pub-id-type="pmid">30471527</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name><name><surname>Runtsch</surname><given-names>MC</given-names></name><name><surname>Kagele</surname><given-names>DA</given-names></name><name><surname>Mosbruger</surname><given-names>TL</given-names></name><name><surname>Tolmachova</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Exosome-delivered micrornas modulate the inflammatory response to endotoxin</article-title>. <source>Nat Commun</source>. (<year>2015</year>) <volume>6</volume>:<fpage>7321</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8321</pub-id><?supplied-pmid 26084661?><pub-id pub-id-type="pmid">26084661</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cione</surname><given-names>E</given-names></name><name><surname>La Torre</surname><given-names>C</given-names></name><name><surname>Cannataro</surname><given-names>R</given-names></name><name><surname>Caroleo</surname><given-names>MC</given-names></name><name><surname>Plastina</surname><given-names>P</given-names></name><name><surname>Gallelli</surname><given-names>L</given-names></name></person-group>. <article-title>Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human microRNA modulation</article-title>. <source>Molecules</source>. (<year>2019</year>) <volume>25</volume>:<fpage>63</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25010063</pub-id><?supplied-pmid 31878082?><pub-id pub-id-type="pmid">31878082</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Ross</surname><given-names>SA</given-names></name><name><surname>Zempleni</surname><given-names>J</given-names></name></person-group>. <article-title>Nutrition, microRNAS, and human health</article-title>. <source>Adv Nutr</source>. (<year>2017</year>) <volume>8</volume>:<fpage>105</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3945/an.116.013839</pub-id><?supplied-pmid 28096131?><pub-id pub-id-type="pmid">28096131</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannataro</surname><given-names>R</given-names></name><name><surname>Perri</surname><given-names>M</given-names></name><name><surname>Gallelli</surname><given-names>L</given-names></name><name><surname>Caroleo</surname><given-names>MC</given-names></name><name><surname>De Sarro</surname><given-names>G</given-names></name><name><surname>Cione</surname><given-names>E</given-names></name></person-group>. <article-title>Ketogenic diet acts on body remodeling and microRNAS expression profile</article-title>. <source>Microrna</source>. (<year>2019</year>) <volume>8</volume>:<fpage>116</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.2174/2211536608666181126093903</pub-id><?supplied-pmid 30474543?><pub-id pub-id-type="pmid">30474543</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannataro</surname><given-names>R</given-names></name><name><surname>Caroleo</surname><given-names>MC</given-names></name><name><surname>Fazio</surname><given-names>A</given-names></name><name><surname>La Torre</surname><given-names>C</given-names></name><name><surname>Plastina</surname><given-names>P</given-names></name><name><surname>Gallelli</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Ketogenic diet and microRNAS linked to antioxidant biochemical homeostasis</article-title>. <source>Antioxidants</source>. (<year>2019</year>) <volume>8</volume>:<fpage>269</fpage>. <pub-id pub-id-type="doi">10.3390/antiox8080269</pub-id><?supplied-pmid 31382449?><pub-id pub-id-type="pmid">31382449</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>JX</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><etal/></person-group>. <article-title>Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea</article-title>. <source>Acta Pharmacol Sin</source>. (<year>2012</year>) <volume>33</volume>:<fpage>1533</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2012.80</pub-id><?supplied-pmid 22941291?><pub-id pub-id-type="pmid">22941291</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Hua</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>J Ethnopharmacol</source>. (<year>2013</year>) <volume>150</volume>:<fpage>521</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2013.08.056</pub-id><?supplied-pmid 24051026?><pub-id pub-id-type="pmid">24051026</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Santis</surname><given-names>S</given-names></name><name><surname>Kunde</surname><given-names>D</given-names></name><name><surname>Serino</surname><given-names>G</given-names></name><name><surname>Galleggiante</surname><given-names>V</given-names></name><name><surname>Caruso</surname><given-names>ML</given-names></name><name><surname>Mastronardi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNF&#x003b1; secretion</article-title>. <source>Oncotarget</source>. (<year>2016</year>) <volume>7</volume>:<fpage>75800</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.12415</pub-id><?supplied-pmid 27716626?><pub-id pub-id-type="pmid">27716626</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yahfoufi</surname><given-names>N</given-names></name><name><surname>Alsadi</surname><given-names>N</given-names></name><name><surname>Jambi</surname><given-names>M</given-names></name><name><surname>Matar</surname><given-names>C</given-names></name></person-group>. <article-title>The immunomodulatory and anti-inflammatory role of polyphenols</article-title>. <source>Nutrients</source>. (<year>2018</year>) <volume>10</volume>:<fpage>1618</fpage>. <pub-id pub-id-type="doi">10.3390/nu10111618</pub-id><?supplied-pmid 30400131?><pub-id pub-id-type="pmid">30400131</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>Y</given-names></name></person-group>. <article-title>Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection</article-title>. <source>Biochimi Biophys Acta</source>. (<year>2015</year>) <volume>1851</volume>:<fpage>496</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2015.01.006</pub-id><?supplied-pmid 25617737?><pub-id pub-id-type="pmid">25617737</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidelmann</surname><given-names>SB</given-names></name><name><surname>Claggett</surname><given-names>B</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Henglin</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><name><surname>Steffen</surname><given-names>LM</given-names></name><etal/></person-group>. <article-title>Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis</article-title>. <source>Lancet Public Health</source>. (<year>2018</year>) <volume>3</volume>:<fpage>e419</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(18)30135-X</pub-id><?supplied-pmid 30122560?><pub-id pub-id-type="pmid">30122560</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cena</surname><given-names>H</given-names></name><name><surname>Calder</surname><given-names>PC</given-names></name></person-group>. <article-title>Defining a healthy diet: evidence for the role of contemporary dietary patterns in health and disease</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<fpage>334</fpage>. <pub-id pub-id-type="doi">10.3390/nu12020334</pub-id><?supplied-pmid 32012681?><pub-id pub-id-type="pmid">32012681</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salas-Salvad&#x000f3;</surname><given-names>J</given-names></name><name><surname>D&#x000ed;az-L&#x000f3;pez</surname><given-names>A.</given-names></name><name><surname>Ruiz-Canela</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>PREDIMED-Plus investigators. effect of a lifestyle intervention program with energy-restricted mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial</article-title>. <source>Diabetes Care</source>. (<year>2018</year>) <volume>42</volume>:<fpage>777</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.2337/dc18-0836</pub-id><pub-id pub-id-type="pmid">30389673</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikari</surname><given-names>SP</given-names></name><name><surname>Meng</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>YJ</given-names></name><name><surname>Mao</surname><given-names>YP</given-names></name><name><surname>Ye</surname><given-names>RX</given-names></name><name><surname>Wang</surname><given-names>QZ</given-names></name><etal/></person-group>. <article-title>Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review</article-title>. <source>Infect Dis Poverty</source>. (<year>2020</year>) <volume>9</volume>:<fpage>29</fpage>. <pub-id pub-id-type="doi">10.1186/s40249-020-00646-x</pub-id><?supplied-pmid 32183901?><pub-id pub-id-type="pmid">32183901</pub-id></mixed-citation></ref></ref-list></back></article>